Literature DB >> 29452729

Postoperative pneumonia among patients with and without COPD in Spain from 2001 to 2015.

Javier de Miguel-Díez1, Ana López-de-Andrés2, Valentín Hernández-Barrera3, Isabel Jiménez-Trujillo3, Manuel Méndez-Bailón4, José María de Miguel-Yanes5, Rodrigo Jiménez-García3.   

Abstract

BACKGROUND: To describe and compare incidence, characteristics and outcomes of postoperative pneumonia among patients with or without COPD.
METHODS: We included hospitalized patients aged ≥40 years whose medical diagnosis included pneumonia and ventilator-associated pneumonia in the secondary's diagnosis field and who were discharged from Spanish hospitals from 2001 to 2015. Irrespectively of the position at the procedures coding list, we retrieved data about the type of surgical procedures using the enhanced ICD-9-CM codes. We grouped admissions by COPD status. The data were collected from the National Hospital Discharge Database.
RESULTS: We included 117,665 hospitalizations of patients that developed postoperative pneumonia (18.06% of them had COPD). The incidence of postoperative pneumonia was significantly higher in COPD patients than in those without COPD (IRR 1.93, 95%CI 1.68-2.24). In hospital-mortality (IHM) was significantly lower in the first group of patients (29.79% vs 31.43%, p < 0.05). Factors independently associated with IHM, among COPD and non-COPD patients, were older age, more comorbidities, mechanical ventilation, pleural drainage tube, red blood cell transfusion, dialysis and emergency room admission. Time trend analysis showed a significant decrease in IHM from 2001 to 2015. COPD was associated with lower IHM (OR 0.91, 95%CI 0.88-0.95).
CONCLUSIONS: The incidence of postoperative pneumonia was higher in COPD patients than in those without this disease. However, IHM was lower among COPD patients. IHM decreased over time, regardless of the existence or not of COPD.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COPD; In-hospital mortality; Incidence; Postoperative pneumonia; Trends

Mesh:

Year:  2018        PMID: 29452729     DOI: 10.1016/j.ejim.2018.02.011

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  Risk factors for postoperative pneumonia after general and digestive surgery: a retrospective single-center study.

Authors:  Hayato Baba; Ryutaro Tokai; Katsuhisa Hirano; Toru Watanabe; Kazuto Shibuya; Isaya Hashimoto; Shozo Hojo; Isaku Yoshioka; Tomoyuki Okumura; Takuya Nagata; Tsutomu Fujii
Journal:  Surg Today       Date:  2019-11-11       Impact factor: 2.549

2.  A nationwide analysis on the effects of chronic obstructive pulmonary disease following primary total shoulder arthroplasty for glenohumeral osteoarthritis.

Authors:  Brandon Amirian; Kyrillos M Akhnoukh; Asad M Ashraf; Samuel J Swiggett; Francis E Rosato; Rushabh M Vakharia; Ramin Sadeghpour; Afshin E Razi
Journal:  Shoulder Elbow       Date:  2021-02-25

3.  Association of Severe Obesity and Chronic Obstructive Pulmonary Disease With Pneumonia Following Non-Cardiac Surgery.

Authors:  Kwaku Owusu-Bediako; Kayla Pfaff; Nguyen K Tram; David L Stahl; Joseph D Tobias; Olubukola O Nafiu; Christian Mpody
Journal:  J Clin Med Res       Date:  2022-06-27

4.  National Trends In Kidney, Heart And Liver Transplants Among Patients With And Without Chronic Obstructive Pulmonary Disease In Spain (2001-2015).

Authors:  Javier de Miguel-Díez; Rodrigo Jiménez-García; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Ana López-de-Andres
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-26

5.  Trends, characteristics, in-hospital outcomes and mortality in surgical mitral valve replacement among patients with and without COPD in Spain (2001-2015).

Authors:  Javier de-Miguel-Díez; Ana López-de-Andrés; Valentín Hernández-Barrera; José M De Miguel-Yanes; Manuel Méndez-Bailón; Nuria Muñoz-Rivas; Rodrigo Jiménez-García
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.